Oaktree Acquisition III Life Sciences (Nasdaq:OACC.U) - Stock Price, News & Analysis

OACC.U Stock Overview

Focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. More details

OACC.U fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Oaktree Acquisition Corp. III Life Sciences Competitors

Silvercrest Asset Management Group

NasdaqGM:SAMG

US$253.2m

GSR III Acquisition

NasdaqGM:GSRT.U

US$261.1m

Ellington Credit

NYSE:EARN

US$194.4m

Helios Fairfax Partners

OTCPK:FFXX.F

US$293.2m

Price History & Performance

Summary of all time highs, changes and price drops for Oaktree Acquisition III Life Sciences
Historical stock prices
Current Share Price	US$10.06
52 Week High	US$10.22
52 Week Low	US$9.99
Beta	0
11 Month Change	0.60%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0.60%

Recent updates

Shareholder Returns

	OACC.U	US Capital Markets	US Market
7D	-0.2%	2.5%	1.6%
1Y	n/a	55.7%	32.3%

Return vs Industry: Insufficient data to determine how OACC.U performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how OACC.U performed against the US Market.

Price Volatility

Is OACC.U's price volatile compared to industry and market?
OACC.U volatility
OACC.U Average Weekly Movement	n/a
Capital Markets Industry Average Movement	3.8%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: OACC.U's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine OACC.U's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2024	n/a	Zaid Pardesi	www.oaktreeacquisitioncorp.com/oac-iii

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Oaktree Acquisition Corp. III Life Sciences Fundamentals Summary

How do Oaktree Acquisition III Life Sciences's earnings and revenue compare to its market cap?
OACC.U fundamental statistics
Market cap	US$226.49m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is OACC.U overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OACC.U income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did OACC.U perform over the long term?

See historical performance and comparison

Oaktree Acquisition III Life Sciences NasdaqGM:OACC.U Stock Report